StockNews.com assumed coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Free Report) in a report released on Sunday. The firm issued a sell rating on the specialty pharmaceutical company’s stock.
Agile Therapeutics Stock Performance
NASDAQ AGRX opened at $1.46 on Friday. The firm has a market capitalization of $10.01 million, a PE ratio of -0.40 and a beta of 1.58. The business’s 50-day moving average price is $1.22 and its two-hundred day moving average price is $0.80. Agile Therapeutics has a 12 month low of $0.20 and a 12 month high of $2.63.
Agile Therapeutics (NASDAQ:AGRX – Get Free Report) last announced its earnings results on Monday, August 12th. The specialty pharmaceutical company reported ($0.68) EPS for the quarter. The company had revenue of $5.58 million during the quarter.
Institutional Trading of Agile Therapeutics
Agile Therapeutics Company Profile
Agile Therapeutics, Inc, a women's healthcare company, engages in the research, development, and commercialization of prescription contraceptive products for women in the United States. It offers Twirla, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen.
Read More
- Five stocks we like better than Agile Therapeutics
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Columbia Sportswear: A Turnaround Story That’s Gaining Ground
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Lowe’s Stock: Hold Now, Buy it When it Dips
- Canada Bond Market Holiday: How to Invest and Trade
- ZIM Shipping Stock Soars as the Industry Shows a Bottoming Trend
Receive News & Ratings for Agile Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agile Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.